Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group (Q44405241)
Jump to navigation
Jump to search
scientific article published in April 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group |
scientific article published in April 2003 |
Statements
1 reference
Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group (English)
1 reference
1 reference
I Tannock
1 reference
C A Townsley
1 reference
K Chi
1 reference
D S Ernst
1 reference
K Belanger
1 reference
D Stewart
1 reference
R Goel
1 reference
J D Ruether
1 reference
L L Siu
1 reference
J Jolivet
1 reference
L McIntosh
1 reference
L Seymour
1 reference
M J Moore
1 reference
National Cancer Institute of Canada-Clinical Trials Group
1 reference
1 April 2003
1 reference
1 reference
Identifiers
1 reference